Log in

Analysts Hate These 12 Stocks in 2020

Posted on Sunday, January 26th, 2020 by MarketBeat Staff

When a single Wall Street analyst downgrades one of your stocks, you might think they are just having a bad day or have an incorrect investment thesis. One downgrade typically won't have a significant impact on the price of one of your stocks, but what if a company was repeatedly downgraded by analysts over the last 30, 60 or 90 days? You would know something is seriously wrong.

Today, we are inviting you to take a free exclusive look at our up-to-the-minute list of 12 "Most Downgraded" stocks. These are true strong sell stocks. Analysts are abandoning them in droves and issuing rare downgrades and sell ratings. If any of these stocks are lurking around in your portfolio, seriously consider whether or not they still belong in your portfolio. .

#1 - Tullow Oil (LON:TLW)

Number of Downgrades: 23 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 2.1
Ratings Breakdown: 3 Buy Ratings, 11 Hold Ratings, 1 Sell Ratings.
Consensus Price Target: GBX 93.71 (80.4% Upside)

Tullow Oil logoTullow Oil plc engages in the oil and gas exploration, development, and production activities primarily in Africa and South America. Its portfolio comprises 87 licenses covering 267,649 square kilometers in 17 countries. The company was founded in 1985 and is headquartered in London, the United Kingdom.

Recent Recommendations for Tullow Oil:

  • Tullow Oil plc (LON: TLW) had its "neutral" rating re-affirmed by analysts at Citigroup Inc. (1/24/2020)
  • Tullow Oil plc (LON: TLW) had its price target raised by analysts at Canaccord Genuity from GBX 55 to GBX 60. They now have a "hold" rating on the stock. (1/20/2020)
  • Tullow Oil plc (LON: TLW) was downgraded by analysts at Barclays PLC to an "equal weight" rating. (1/16/2020)
  • Tullow Oil plc (LON: TLW) had its "hold" rating re-affirmed by analysts at Peel Hunt LLP. They now have a GBX 75 price target on the stock. (1/15/2020)
  • Tullow Oil plc (LON: TLW) had its "hold" rating re-affirmed by analysts at Peel Hunt. They now have a GBX 75 price target on the stock. (1/15/2020)
  • Tullow Oil plc (LON: TLW) had its price target lowered by analysts at JPMorgan Chase & Co. from GBX 249 to GBX 63. They now have a "neutral" rating on the stock. (1/10/2020)
  • Tullow Oil plc (LON: TLW) was downgraded by analysts at Barclays PLC to an "equal weight" rating. They now have a GBX 75 price target on the stock, down previously from GBX 80. (1/9/2020)
  • Tullow Oil plc (LON: TLW) had its "hold" rating re-affirmed by analysts at Peel Hunt. (1/2/2020)
  • Tullow Oil plc (LON: TLW) had its "neutral" rating re-affirmed by analysts at UBS Group AG. They now have a GBX 60 price target on the stock, down previously from GBX 220. (12/19/2019)
  • Tullow Oil plc (LON: TLW) had its price target lowered by analysts at Jefferies Financial Group Inc from GBX 168 to GBX 65. They now have a "hold" rating on the stock. (12/19/2019)
#2 - Dollar Tree (NASDAQ:DLTR)

Number of Downgrades: 20 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 2.4
Ratings Breakdown: 10 Buy Ratings, 10 Hold Ratings, 2 Sell Ratings.
Consensus Price Target: $103.76 (18.3% Upside)

Dollar Tree logoDollar Tree, Inc. operates discount variety retail stores. It operates through two segments, Dollar Tree and Family Dollar. The Dollar Tree segment offers merchandise at the fixed price of $1.00. It provides consumable merchandise, including candy and food, and health and beauty care, as well as everyday consumables, such as household paper and chemicals, and frozen and refrigerated food; variety merchandise comprising toys, durable housewares, gifts, stationery, party goods, greeting cards, softlines, and other items; and seasonal goods that include Valentine's Day, Easter, Halloween, and Christmas merchandise. This segment operates 7,001 stores under the Dollar Tree and Dollar Tree Canada brands, as well as 12 distribution centers in the United States and 2 in Canada; and a store support center in Chesapeake, Virginia. The Family Dollar segment operates general merchandise discount retail stores that offer consumable merchandise, which comprise food and beverages, tobacco, health and beauty aids, household chemicals, paper products, hardware and automotive supplies, diapers, batteries, and pet food and supplies; and home products, including housewares, home décor, and giftware, as well as domestics, such as comforters, sheets, and towels. Its stores also provides apparel and accessories merchandise comprising clothing, fashion accessories, and shoes; and seasonal and electronics merchandise that include Valentine's Day, Easter, Halloween, and Christmas merchandise, as well as personal electronics, which comprise pre-paid cellular phones and services, stationery and school supplies, and toys. This segment operates stores under the Family Dollar brand; and 11 distribution centers, as well as a store support center in Matthews, North Carolina. The company was founded in 1986 and is headquartered in Chesapeake, Virginia.

Recent Recommendations for Dollar Tree:

  • Dollar Tree, Inc. (NASDAQ: DLTR) had its "buy" rating re-affirmed by analysts at Sanford C. Bernstein. They now have a $110.00 price target on the stock. (1/24/2020)
  • Dollar Tree, Inc. (NASDAQ: DLTR) was downgraded by analysts at Bank of America Corp from a "buy" rating to a "neutral" rating. They now have a $95.00 price target on the stock, down previously from $105.00. (1/23/2020)
  • Dollar Tree, Inc. (NASDAQ: DLTR) had its price target raised by analysts at Morgan Stanley from $95.00 to $105.00. They now have an "equal weight" rating on the stock. (1/22/2020)
  • Dollar Tree, Inc. (NASDAQ: DLTR) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. (1/18/2020)
  • Dollar Tree, Inc. (NASDAQ: DLTR) was downgraded by analysts at Gordon Haskett from an "accumulate" rating to a "reduce" rating. They now have a $85.00 price target on the stock, down previously from $106.00. (1/8/2020)
  • Dollar Tree, Inc. (NASDAQ: DLTR) was downgraded by analysts at Loop Capital from a "hold" rating to a "sell" rating. They now have a $74.00 price target on the stock, down previously from $94.00. (1/6/2020)
  • Dollar Tree, Inc. (NASDAQ: DLTR) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. (12/21/2019)
  • Dollar Tree, Inc. (NASDAQ: DLTR) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. (12/11/2019)
  • Dollar Tree, Inc. (NASDAQ: DLTR) had its "buy" rating re-affirmed by analysts at Wells Fargo & Co. (12/9/2019)
  • Dollar Tree, Inc. (NASDAQ: DLTR) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. (12/4/2019)
#3 - GrubHub (NYSE:GRUB)

Number of Downgrades: 19 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 2.1
Ratings Breakdown: 5 Buy Ratings, 20 Hold Ratings, 2 Sell Ratings.
Consensus Price Target: $62.75 (7.1% Upside)

GrubHub logoGrubhub Inc., together with its subsidiaries, provides an online and mobile platform for restaurant pick-up and delivery orders in the United States. The company connects approximately 105,000 local restaurants with diners with diners in various cities. It offers Grubhub, Seamless, and Eat24 mobile applications and mobile Websites; and operates Websites through grubhub.com, seamless.com, eat24.com, and menupages.com. The company also provides corporate program that offers employees with various food and ordering options, including options for individual meals, group ordering, and catering, as well as proprietary tools that consolidate various food ordering into a single online account. In addition, it offers Allmenus.com and MenuPages.com, which provide an aggregated database of approximately 440,000 menus from restaurants in 50 U.S. states; Grubhub for Restaurants, a responsive Web application that can be accessed from computers and mobile devices, as well as Grubhub-provided tablets; point of sale (POS) integration, which allows restaurants to manage Grubhub orders and update their menus directly from their existing POS system; and Website and mobile application design and hosting services for restaurants, as well as technology and fulfillment services, including order transmission and customer relationship management tools. The company was formerly known as GrubHub Seamless Inc. and changed its name to Grubhub Inc. in February 2014. Grubhub Inc. was founded in 1999 and is headquartered in Chicago, Illinois.

Recent Recommendations for GrubHub:

  • GrubHub Inc (NYSE: GRUB) had its price target raised by analysts at Morgan Stanley from $33.00 to $60.00. They now have an "equal weight" rating on the stock. (1/21/2020)
  • GrubHub Inc (NYSE: GRUB) had its price target raised by analysts at Wells Fargo & Co from $35.00 to $60.00. (1/17/2020)
  • GrubHub Inc (NYSE: GRUB) had its price target raised by analysts at Goldman Sachs Group Inc from $42.00 to $54.00. They now have a "neutral" rating on the stock. (1/15/2020)
  • GrubHub Inc (NYSE: GRUB) had its price target raised by analysts at Wedbush from $30.00 to $45.00. They now have a "neutral" rating on the stock. (1/9/2020)
  • GrubHub Inc (NYSE: GRUB) had its "hold" rating re-affirmed by analysts at Morgan Stanley. They now have a $33.00 price target on the stock. (1/9/2020)
  • GrubHub Inc (NYSE: GRUB) had its "hold" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $40.00 price target on the stock. (1/8/2020)
  • GrubHub Inc (NYSE: GRUB) had its "outperform" rating re-affirmed by analysts at Credit Suisse Group AG. They now have a $52.00 price target on the stock, up previously from $42.00. (1/6/2020)
  • GrubHub Inc (NYSE: GRUB) had its price target raised by analysts at Canaccord Genuity from $44.00 to $52.00. They now have a "buy" rating on the stock. (12/19/2019)
  • GrubHub Inc (NYSE: GRUB) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. They now have a $47.00 price target on the stock. (12/17/2019)
  • GrubHub Inc (NYSE: GRUB) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. They now have a $45.00 price target on the stock. (11/27/2019)
#4 - Arista Networks (NYSE:ANET)

Number of Downgrades: 18 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 2.4
Ratings Breakdown: 11 Buy Ratings, 11 Hold Ratings, 1 Sell Ratings.
Consensus Price Target: $226.96 (-4.7% Upside)

Arista Networks logoArista Networks, Inc. develops, markets, and sells cloud networking solutions in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company's cloud networking solutions consist of extensible operating systems, a set of network applications, as well as gigabit Ethernet switching and routing platforms, including universal leaf, spline, and universal spine products. It also provides post contract customer support services, such as technical support, hardware repair and parts replacement beyond standard warranty, bug fix, patch, and upgrade services. The company serves a range of industries comprising Internet companies, service providers, financial services organizations, government agencies, media and entertainment companies, and others. It markets and sells its products through distributors, value-added resellers, system integrators, and original equipment manufacturer partners, as well as through its direct sales force. The company was formerly known as Arastra, Inc. and changed its name to Arista Networks, Inc. in October 2008. Arista Networks, Inc. was founded in 2004 and is headquartered in Santa Clara, California.

Recent Recommendations for Arista Networks:

  • Arista Networks Inc (NYSE: ANET) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. (1/4/2020)
  • Arista Networks Inc (NYSE: ANET) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. (12/3/2019)
  • Arista Networks Inc (NYSE: ANET) is now covered by analysts at New Street Research. They set a "buy" rating and a $250.00 price target on the stock. (11/27/2019)
  • Arista Networks Inc (NYSE: ANET) is now covered by analysts at New Street Research. They set a "buy" rating and a $250.00 price target on the stock. (11/19/2019)
  • Arista Networks Inc (NYSE: ANET) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. (11/6/2019)
  • Arista Networks Inc (NYSE: ANET) had its price target lowered by analysts at UBS Group AG from $285.00 to $200.00. They now have a "neutral" rating on the stock. (11/4/2019)
  • Arista Networks Inc (NYSE: ANET) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. They now have a $180.00 price target on the stock, down previously from $290.00. (11/1/2019)
  • Arista Networks Inc (NYSE: ANET) had its price target lowered by analysts at Wolfe Research from $270.00 to $200.00. They now have a "peer perform" rating on the stock. (11/1/2019)
  • Arista Networks Inc (NYSE: ANET) had its price target lowered by analysts at Piper Jaffray Companies from $272.00 to $213.00. They now have an "overweight" rating on the stock. (11/1/2019)
  • Arista Networks Inc (NYSE: ANET) had its price target lowered by analysts at Cowen Inc from $295.00 to $212.00. They now have an "outperform" rating on the stock. (11/1/2019)
#5 - Expedia Group (NASDAQ:EXPE)

Number of Downgrades: 16 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 2.4
Ratings Breakdown: 10 Buy Ratings, 16 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $139.32 (24.2% Upside)

Expedia Group logoExpedia Group, Inc., together with its subsidiaries, operates as an online travel company in the United States and internationally. It operates through Core OTA, Trivago, HomeAway, and Egencia segments. The company facilitates the booking of hotel rooms, alternative accommodations, airline seats, car rentals, and destination services from its travel suppliers; and acts as an agent in the transactions. It serves leisure and corporate travelers, including travel agencies, tour operators, travel supplier direct websites and their call centers. The company also engages in advertising and media business. The company was formerly known as Expedia, Inc. and changed its name to Expedia Group, Inc. in March 2018. Expedia Group, Inc. was founded in 1996 and is headquartered in Bellevue, Washington.

Recent Recommendations for Expedia Group:

  • Expedia Group Inc (NASDAQ: EXPE) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. (12/11/2019)
  • Expedia Group Inc (NASDAQ: EXPE) had its "hold" rating re-affirmed by analysts at Needham & Company LLC. (12/5/2019)
  • Expedia Group Inc (NASDAQ: EXPE) had its price target lowered by analysts at Royal Bank of Canada from $142.00 to $125.00. They now have an "outperform" rating on the stock. (12/4/2019)
  • Expedia Group Inc (NASDAQ: EXPE) had its price target lowered by analysts at Mizuho from $115.00 to $100.00. (12/2/2019)
  • Expedia Group Inc (NASDAQ: EXPE) had its "buy" rating re-affirmed by analysts at SunTrust Banks, Inc.. They now have a $172.00 price target on the stock. (11/21/2019)
  • Expedia Group Inc (NASDAQ: EXPE) is now covered by analysts at Consumer Edge. They set an "equal weight" rating and a $100.00 price target on the stock. (11/18/2019)
  • Expedia Group Inc (NASDAQ: EXPE) was downgraded by analysts at TheStreet from a "b" rating to a "c+" rating. (11/18/2019)
  • Expedia Group Inc (NASDAQ: EXPE) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. (11/15/2019)
  • Expedia Group Inc (NASDAQ: EXPE) was downgraded by analysts at Oppenheimer Holdings Inc. from an "outperform" rating to a "market perform" rating. They now have a $110.00 price target on the stock, down previously from $160.00. (11/11/2019)
  • Expedia Group Inc (NASDAQ: EXPE) was downgraded by analysts at JMP Securities from an "outperform" rating to a "market perform" rating. (11/8/2019)
#6 - SAGE Therapeutics (NASDAQ:SAGE)

Number of Downgrades: 16 (in the last 90 days)
Consensus Rating: Buy
Rating Score: 2.7
Ratings Breakdown: 13 Buy Ratings, 6 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $127.00 (86.7% Upside)

SAGE Therapeutics logoSage Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel medicines to treat central nervous system (CNS) disorders. Its lead product candidate is ZULRESSO, a proprietary intravenous formulation of brexanolone that has completed Phase III clinical trials for the treatment of postpartum depression (PPD). The company's product pipeline also includes SAGE-217, a novel neuroactive steroid, which is in Phase III clinical trials for treating PPD, major depressive disorders, bipolar depression, and sleep disorders; and SAGE-324, a novel neuroactive steroid that has completed Phase I clinical trials to treat various neurological conditions, including essential tremor and epileptiform disorders. In addition, its product pipeline comprises SAGE-718, an oxysterol-based positive allosteric modulator of the NMDA receptor, which has completed Phase I clinical trial for the treatment of depression, Huntington's disease, Alzheimer's disease, attention deficit hyperactivity disorder, schizophrenia, and neuropathic pain; and SAGE-689, a novel GABAA receptor positive allosteric modulator that is in preclinical stage to treat acute and chronic CNS disorders. Sage Therapeutics, Inc. has a strategic collaboration with Shionogi & Co., Ltd. for the development and commercialization of SAGE-217 in Japan, Taiwan, and South Korea. The company was formerly known as Sterogen Biopharma, Inc. and changed its name to Sage Therapeutics, Inc. in September 2011. Sage Therapeutics, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Recent Recommendations for SAGE Therapeutics:

  • SAGE Therapeutics Inc (NASDAQ: SAGE) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. (1/24/2020)
  • SAGE Therapeutics Inc (NASDAQ: SAGE) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. (1/7/2020)
  • SAGE Therapeutics Inc (NASDAQ: SAGE) had its price target raised by analysts at Bank of America Corp from to . (1/7/2020)
  • SAGE Therapeutics Inc (NASDAQ: SAGE) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. (1/1/2020)
  • SAGE Therapeutics Inc (NASDAQ: SAGE) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. (12/24/2019)
  • SAGE Therapeutics Inc (NASDAQ: SAGE) had its price target lowered by analysts at JPMorgan Chase & Co. from $200.00 to $105.00. They now have an "overweight" rating on the stock. (12/6/2019)
  • SAGE Therapeutics Inc (NASDAQ: SAGE) had its price target lowered by analysts at Morgan Stanley from $217.00 to $125.00. They now have an "overweight" rating on the stock. (12/6/2019)
  • SAGE Therapeutics Inc (NASDAQ: SAGE) had its price target lowered by analysts at Royal Bank of Canada from $190.00 to $100.00. They now have an "outperform" rating on the stock. (12/6/2019)
  • SAGE Therapeutics Inc (NASDAQ: SAGE) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $92.00 price target on the stock. (12/6/2019)
  • SAGE Therapeutics Inc (NASDAQ: SAGE) was downgraded by analysts at LADENBURG THALM/SH SH from a "buy" rating to a "neutral" rating. (12/6/2019)
#7 - Pearson (LON:PSON)

Number of Downgrades: 15 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 1.8
Ratings Breakdown: 2 Buy Ratings, 5 Hold Ratings, 5 Sell Ratings.
Consensus Price Target: GBX 629.82 (7.9% Upside)

Pearson logoPearson plc provides educational products and services to institutions, governments, professional bodies, and individual learners worldwide. The company operates through North America, Core, and Growth segments. It offers courseware services, including curriculum materials provided in book form and/or through access to digital content; and assessments, such as test development, processing, and scoring services. The company also operates schools, colleges, and universities; and provides online learning services in partnership with universities and other academic institutions. In addition, it delivers and installs off-the-shelf software; and provides services to academic institutions, such as program development, student acquisition, education technology, and student support services, as well as undertakes contracts to process qualifying tests for individual professions and government departments under multi-year contractual arrangements. The company was founded in 1844 and is headquartered in London, the United Kingdom.

Recent Recommendations for Pearson:

  • Pearson plc (LON: PSON) had its price target lowered by analysts at Deutsche Bank AG from GBX 600 to GBX 500. They now have a "hold" rating on the stock. (1/24/2020)
  • Pearson plc (LON: PSON) was downgraded by analysts at UBS Group AG to a "neutral" rating. They now have a GBX 600 price target on the stock, down previously from GBX 820. (1/21/2020)
  • Pearson plc (LON: PSON) had its price target lowered by analysts at Barclays PLC from GBX 620 to GBX 520. They now have an "underweight" rating on the stock. (1/17/2020)
  • Pearson plc (LON: PSON) had its price target lowered by analysts at Goldman Sachs Group Inc from GBX 566 to GBX 518. They now have a "sell" rating on the stock. (1/17/2020)
  • Pearson plc (LON: PSON) had its price target lowered by analysts at Kepler Capital Markets from GBX 815 to GBX 650. They now have a "hold" rating on the stock. (1/17/2020)
  • Pearson plc (LON: PSON) had its price target lowered by analysts at JPMorgan Chase & Co. from GBX 950 to GBX 860. They now have an "overweight" rating on the stock. (1/16/2020)
  • Pearson plc (LON: PSON) had its "hold" rating re-affirmed by analysts at Shore Capital. (1/16/2020)
  • Pearson plc (LON: PSON) had its "sell" rating re-affirmed by analysts at Liberum Capital. (1/15/2020)
  • Pearson plc (LON: PSON) had its price target lowered by analysts at Citigroup Inc from GBX 1,000 to GBX 960. They now have a "buy" rating on the stock. (1/15/2020)
  • Pearson plc (LON: PSON) had its price target lowered by analysts at Credit Suisse Group AG from GBX 680 to GBX 590. They now have an "underperform" rating on the stock. (1/14/2020)
#8 - Tiffany & Co. (NYSE:TIF)

Number of Downgrades: 14 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 2.2
Ratings Breakdown: 3 Buy Ratings, 17 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $122.29 (-8.9% Upside)

Tiffany & Co. logoTiffany & Co., through its subsidiaries, designs, manufactures, and retails jewelry and other items in the Americas, the Asia-Pacific, Japan, Europe, and internationally. The company offers jewelry collections, engagement rings, and wedding bands. It also sells watches, home and accessories products, eyewear, and fragrances; and wholesales diamonds and earnings. The company sells its products through retail, Internet and catalog, business-to-business, and wholesale distribution channels. As of January 31, 2019, it operated 124 stores in the Americas, 90 stores in the Asia-Pacific, 55 stores in Japan, 47 stores in Europe, and 5 stores in the United Arab Emirates. Tiffany & Co. was founded in 1837 and is headquartered in New York, New York.

Recent Recommendations for Tiffany & Co.:

  • Tiffany & Co. (NYSE: TIF) was downgraded by analysts at Cowen Inc from an "outperform" rating to a "market perform" rating. They now have a $135.00 price target on the stock, down previously from $160.00. (12/9/2019)
  • Tiffany & Co. (NYSE: TIF) was downgraded by analysts at Credit Suisse Group AG from an "outperform" rating to a "neutral" rating. They now have a $135.00 price target on the stock. (12/6/2019)
  • Tiffany & Co. (NYSE: TIF) had its "hold" rating re-affirmed by analysts at Loop Capital. They now have a $135.00 price target on the stock. (12/6/2019)
  • Tiffany & Co. (NYSE: TIF) had its price target raised by analysts at Wells Fargo & Co from $100.00 to $125.00. (11/27/2019)
  • Tiffany & Co. (NYSE: TIF) was downgraded by analysts at Atlantic Securities from an "overweight" rating to a "neutral" rating. They now have a $135.00 price target on the stock. (11/26/2019)
  • Tiffany & Co. (NYSE: TIF) was downgraded by analysts at Telsey Advisory Group from an "outperform" rating to a "market perform" rating. They now have a $135.00 price target on the stock. (11/26/2019)
  • Tiffany & Co. (NYSE: TIF) had its price target raised by analysts at Morgan Stanley from $120.00 to $135.00. They now have an "equal weight" rating on the stock. (11/26/2019)
  • Tiffany & Co. (NYSE: TIF) was downgraded by analysts at Evercore ISI to an "outperform" rating. (11/25/2019)
  • Tiffany & Co. (NYSE: TIF) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating. (11/25/2019)
  • Tiffany & Co. (NYSE: TIF) was downgraded by analysts at William Blair from an "outperform" rating to a "market perform" rating. (11/25/2019)
#9 - Kohl's (NYSE:KSS)

Number of Downgrades: 14 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 2.1
Ratings Breakdown: 3 Buy Ratings, 13 Hold Ratings, 2 Sell Ratings.
Consensus Price Target: $50.67 (11.4% Upside)

KohlKohl's Corporation operates as an omni-channel retailer in the United States. Its stores and Website offer apparel, footwear, accessories, beauty, and home products. As of February 3, 2018, it operated 1,158 department stores; a Website Kohls.com; and 12 FILA outlets, and 4 Off-Aisle clearance centers. Kohl's Corporation has a strategic collaboration with Planet Fitness, Inc. to open Planet Fitness stores. The company was founded in 1962 and is headquartered in Menomonee Falls, Wisconsin.

Recent Recommendations for Kohl's:

  • Kohl's Co. (NYSE: KSS) had its price target lowered by analysts at Telsey Advisory Group from $48.00 to $45.00. They now have a "market perform" rating on the stock. (1/10/2020)
  • Kohl's Co. (NYSE: KSS) was downgraded by analysts at Bank of America Corp from a "buy" rating to a "neutral" rating. They now have a $50.00 price target on the stock. (1/9/2020)
  • Kohl's Co. (NYSE: KSS) was downgraded by analysts at Cowen Inc from an "outperform" rating to a "market perform" rating. They now have a $53.00 price target on the stock, down previously from $56.00. (1/8/2020)
  • Kohl's Co. (NYSE: KSS) was downgraded by analysts at Jefferies Financial Group Inc from a "buy" rating to a "hold" rating. They now have a $52.00 price target on the stock, down previously from $65.00. (1/6/2020)
  • Kohl's Co. (NYSE: KSS) was downgraded by analysts at TheStreet from a "b-" rating to a "c" rating. (12/23/2019)
  • Kohl's Co. (NYSE: KSS) had its price target lowered by analysts at Morgan Stanley from $42.00 to $41.00. They now have an "underweight" rating on the stock. (12/19/2019)
  • Kohl's Co. (NYSE: KSS) had its price target lowered by analysts at Goldman Sachs Group Inc from $56.00 to $48.00. (11/27/2019)
  • Kohl's Co. (NYSE: KSS) had its price target lowered by analysts at Robert W. Baird from $65.00 to $58.00. They now have a "positive" rating on the stock. (11/20/2019)
  • Kohl's Co. (NYSE: KSS) had its price target lowered by analysts at Wedbush from $53.00 to $50.00. They now have a "neutral" rating on the stock. (11/20/2019)
  • Kohl's Co. (NYSE: KSS) was downgraded by analysts at Goldman Sachs Group Inc from a "buy" rating to a "neutral" rating. They now have a $48.00 price target on the stock, down previously from $56.00. (11/20/2019)
#10 - Audentes Therapeutics (NASDAQ:BOLD)

Number of Downgrades: 14 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 2.2
Ratings Breakdown: 3 Buy Ratings, 14 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $50.54 (-15.7% Upside)

Audentes Therapeutics logoAudentes Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases caused by single gene defects. The company is developing AT132, which is in Phase I/II clinical studies for the treatment of X-linked myotubular myopathy (XLMTM); AT342 that is in Phase I/II clinical studies to treat crigler-najjar syndrome; AT845, which is in preclinical studies for the treatment of pompe disease; and AT307 to treat CASQ2 subtype of catecholaminergic polymorphic ventricular tachycardia. It is also developing vectorized antisense treatments for the treatment of duchenne muscular dystrophy and myotonic dystrophy type 1. The company has a collaborative development agreement with Genethon to research, develop, manufacture, and commercialize products for the treatment of XLMTM; and a license and collaboration agreement with the University of Pennsylvania to research, develop, sell, and import licensed products for the treatment of crigler-najjar. Audentes Therapeutics, Inc. was founded in 2012 and is headquartered in San Francisco, California.

Recent Recommendations for Audentes Therapeutics:

  • Audentes Therapeutics Inc (NASDAQ: BOLD) had its "hold" rating re-affirmed by analysts at Chardan Capital. (1/20/2020)
  • Audentes Therapeutics Inc (NASDAQ: BOLD) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. (1/13/2020)
  • Audentes Therapeutics Inc (NASDAQ: BOLD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $69.00 price target on the stock. (1/8/2020)
  • Audentes Therapeutics Inc (NASDAQ: BOLD) had its "hold" rating re-affirmed by analysts at Mizuho. They now have a $60.00 price target on the stock. (12/16/2019)
  • Audentes Therapeutics Inc (NASDAQ: BOLD) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $60.00 price target on the stock. (12/5/2019)
  • Audentes Therapeutics Inc (NASDAQ: BOLD) had its "neutral" rating re-affirmed by analysts at Chardan Capital. They now have a $60.00 price target on the stock. (12/4/2019)
  • Audentes Therapeutics Inc (NASDAQ: BOLD) had its "market perform" rating re-affirmed by analysts at Svb Leerink Llc. (12/4/2019)
  • Audentes Therapeutics Inc (NASDAQ: BOLD) was downgraded by analysts at Leerink Swann from an "outperform" rating to a "hold" rating. They now have a $60.00 price target on the stock. (12/4/2019)
  • Audentes Therapeutics Inc (NASDAQ: BOLD) had its price target lowered by analysts at Wells Fargo & Co from $20.00 to $19.00. They now have an "outperform" rating on the stock. (12/3/2019)
  • Audentes Therapeutics Inc (NASDAQ: BOLD) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating. They now have a $60.00 price target on the stock. (12/3/2019)
#11 - Incyte (NASDAQ:INCY)

Number of Downgrades: 13 (in the last 90 days)
Consensus Rating: Buy
Rating Score: 2.5
Ratings Breakdown: 11 Buy Ratings, 10 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $92.25 (20.2% Upside)

Incyte logoIncyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of various therapeutics in the United States. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; and Iclusig, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia. Its clinical stage products include ruxolitinib, a drug in Phase III clinical trial for steroid-refractory acute graft-versus-host-diseases (GVHD); and Phase II trial for the treatment of essential thrombocythemia and refractory myelofibrosis. In addition, the company engages in the development of itacitinib, which is in Phase III clinical trial to treat naïve acute and chronic GVHD, as well as Phase I/II clinical trial in combination with osimertinib for non-small cell lung cancer (NSCLC); and pemigatinib that is in Phase II clinical trial for treating bladder cancer, cholangiocarcinoma, and 8p11 myeloproliferative syndrome, as well as a pivotal program for solid tumors with driver activations of FGF/FGFR. Further, it is involved in developing INCMGA0012 that is in Phase II clinical trials for MSI-high endometrial cancer, merkel cell carcinoma, and anal cancer. Additionally, the company develops Parsaclisib, which is in Phase II clinical trial for follicular lymphoma, marginal zone lymphoma, and mantel cell lymphoma. It has collaboration agreements with Novartis International Pharmaceutical Ltd.; Eli Lilly and Company; Agenus Inc.; Jiangsu Hengrui Medicine Co., Ltd.; Merus N.V.; Calithera Biosciences, Inc; MacroGenics, Inc.; Syros Pharmaceuticals, Inc.; and Innovent Biologics, Inc., as well as BriaCell Therapeutics Corp. for treating cancer. The company was founded in 1991 and is headquartered in Wilmington, Delaware.

Recent Recommendations for Incyte:

  • Incyte Co. (NASDAQ: INCY) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. (1/25/2020)
  • Incyte Co. (NASDAQ: INCY) had its price target raised by analysts at Cantor Fitzgerald from $65.00 to $83.00. They now have a "neutral" rating on the stock. (1/23/2020)
  • Incyte Co. (NASDAQ: INCY) had its "outperform" rating re-affirmed by analysts at JMP Securities. They now have a $121.00 price target on the stock. (1/14/2020)
  • Incyte Co. (NASDAQ: INCY) had its "buy" rating re-affirmed by analysts at JPMorgan Chase & Co.. (1/14/2020)
  • Incyte Co. (NASDAQ: INCY) had its "buy" rating re-affirmed by analysts at Cowen Inc. (1/13/2020)
  • Incyte Co. (NASDAQ: INCY) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. (1/7/2020)
  • Incyte Co. (NASDAQ: INCY) had its "neutral" rating re-affirmed by analysts at Royal Bank of Canada. (1/6/2020)
  • Incyte Co. (NASDAQ: INCY) had its price target lowered by analysts at Morgan Stanley from $89.00 to $83.00. They now have an "equal weight" rating on the stock. (1/6/2020)
  • Incyte Co. (NASDAQ: INCY) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. (1/4/2020)
  • Incyte Co. (NASDAQ: INCY) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $100.00 to $96.00. They now have an "outperform" rating on the stock. (1/3/2020)
#12 - Pinterest (NYSE:PINS)

Number of Downgrades: 13 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 2.5
Ratings Breakdown: 11 Buy Ratings, 13 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $27.91 (24.4% Upside)

Pinterest logoPinterest, Inc. provides a visual discovery engine that helps users to discover ideas for various projects and interests worldwide. Its platform allows users to discover ideas for daily activities, remodeling a house or training for a marathon, ongoing passions, and planning a wedding or a dream vacation. The company's platform show visual recommendations called Pins, based on user personal taste and interests. It also provides Product Pins that make items shoppable with up-to-date pricing; Recipe Pins to cook a meal by bringing the relevant information; Shop the Look, which enables pinners to shop for the individual products they see within fashion and home decor Pins; and Video Pins, which are short videos with topics, such as how-to content about cooking and beauty. The company was formerly known as Cold Brew Labs Inc. and changed its name to Pinterest, Inc. in November 2010. Pinterest, Inc. was incorporated in 2008 and is headquartered in San Francisco, California.

Recent Recommendations for Pinterest:

  • Pinterest (NYSE: PINS) had its price target raised by analysts at Pivotal Research from $23.50 to $25.00. They now have a "hold" rating on the stock. (1/22/2020)
  • Pinterest (NYSE: PINS) was upgraded by analysts at Wells Fargo & Co from an "equal weight" rating to an "overweight" rating. They now have a $30.00 price target on the stock, up previously from $28.00. (1/17/2020)
  • Pinterest (NYSE: PINS) is now covered by analysts at Bernstein Bank. They set a "market perform" rating and a $21.00 price target on the stock. (1/10/2020)
  • Pinterest (NYSE: PINS) is now covered by analysts at Sanford C. Bernstein. They set a "market perform" rating and a $21.00 price target on the stock. (1/9/2020)
  • Pinterest (NYSE: PINS) had its "buy" rating re-affirmed by analysts at Nomura. They now have a $31.00 price target on the stock. (1/6/2020)
  • Pinterest (NYSE: PINS) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. (12/26/2019)
  • Pinterest (NYSE: PINS) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. (12/20/2019)
  • Pinterest (NYSE: PINS) is now covered by analysts at Monness Crespi & Hardt. They set a "neutral" rating on the stock. (12/16/2019)
  • Pinterest (NYSE: PINS) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. (12/11/2019)
  • Pinterest (NYSE: PINS) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. (12/4/2019)
#13 - Wayfair (NYSE:W)

Number of Downgrades: 13 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 2.4
Ratings Breakdown: 13 Buy Ratings, 11 Hold Ratings, 2 Sell Ratings.
Consensus Price Target: $123.83 (16.0% Upside)

Wayfair logoWayfair Inc. engages in the e-commerce business in the United States, Europe, and internationally. It provides approximately 14 million products for the home sector under various brands. The company offers selection of furniture, décor, decorative accents, housewares, seasonal décor, and other home goods through its sites, including Wayfair, Joss & Main, AllModern, Birch Lane, and Perigold. Wayfair Inc. was founded in 2002 and is headquartered in Boston, Massachusetts.

Recent Recommendations for Wayfair:

  • Wayfair Inc (NYSE: W) was downgraded by analysts at Loop Capital from a "buy" rating to a "hold" rating. They now have a $105.00 price target on the stock. (1/23/2020)
  • Wayfair Inc (NYSE: W) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. They now have a $106.00 price target on the stock. (1/15/2020)
  • Wayfair Inc (NYSE: W) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. (1/14/2020)
  • Wayfair Inc (NYSE: W) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. They now have a $99.00 price target on the stock. (1/6/2020)
  • Wayfair Inc (NYSE: W) was upgraded by analysts at Citigroup Inc from a "neutral" rating to a "buy" rating. They now have a $48.00 price target on the stock. (1/6/2020)
  • Wayfair Inc (NYSE: W) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. (1/4/2020)
  • Wayfair Inc (NYSE: W) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. They now have a $94.00 price target on the stock. (12/16/2019)
  • Wayfair Inc (NYSE: W) had its price target lowered by analysts at Morgan Stanley from $117.00 to $75.00. They now have an "equal weight" rating on the stock. (12/16/2019)
  • Wayfair Inc (NYSE: W) is now covered by analysts at SunTrust Banks, Inc.. They set a "hold" rating and a $95.00 price target on the stock. (12/13/2019)
  • Wayfair Inc (NYSE: W) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $110.00 price target on the stock, down previously from $120.00. (12/12/2019)
#14 - H&E Equipment Services (NASDAQ:HEES)

Number of Downgrades: 12 (in the last 90 days)
Consensus Rating: Buy
Rating Score: 2.5
Ratings Breakdown: 2 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $35.00 (21.6% Upside)

H&E Equipment Services logoH&E Equipment Services, Inc. operates as an integrated equipment services company. The company operates in five segments: Equipment Rentals, New Equipment Sales, Used Equipment Sales, Parts Sales, and Repair and Maintenance Services. It rents, sells, and provides parts and support services for hi-lift or aerial work platform equipment, cranes, earthmoving equipment, and industrial lift trucks. The company offers heavy construction and industrial equipment for rent on a daily, weekly, and monthly basis. As of December 31, 2018, its rental fleet consisted of 40,542 pieces of equipment. The company also sells new and used equipment, as well as parts; and provides maintenance and repair services for the customers' owned equipment. In addition, it offers ancillary equipment support activities, including transportation, hauling, parts shipping, and loss damage waivers. The company serves industrial and commercial companies, construction contractors, manufacturers, public utilities, municipalities, maintenance contractors, and various other industrial account customers. As of February 14, 2019, it had a network of 96 full-service facilities serving approximately 41,600 customers across 22 states in the West Coast, Intermountain, Southwest, Gulf Coast, Southeast, and Mid-Atlantic regions of the United States. H&E Equipment Services, Inc. was founded in 1961 and is headquartered in Baton Rouge, Louisiana.

Recent Recommendations for H&E Equipment Services:

  • H&E Equipment Services, Inc. (NASDAQ: HEES) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. (1/25/2020)
  • H&E Equipment Services, Inc. (NASDAQ: HEES) was upgraded by analysts at ValuEngine from a "strong sell" rating to a "sell" rating. (1/21/2020)
  • H&E Equipment Services, Inc. (NASDAQ: HEES) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. (1/15/2020)
  • H&E Equipment Services, Inc. (NASDAQ: HEES) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. (1/11/2020)
  • H&E Equipment Services, Inc. (NASDAQ: HEES) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. (1/4/2020)
  • H&E Equipment Services, Inc. (NASDAQ: HEES) was downgraded by analysts at ValuEngine from a "sell" rating to a "strong sell" rating. (1/3/2020)
  • H&E Equipment Services, Inc. (NASDAQ: HEES) was upgraded by analysts at ValuEngine from a "strong sell" rating to a "sell" rating. (12/27/2019)
  • H&E Equipment Services, Inc. (NASDAQ: HEES) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. (12/17/2019)
  • H&E Equipment Services, Inc. (NASDAQ: HEES) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $38.00 price target on the stock. (12/13/2019)
  • H&E Equipment Services, Inc. (NASDAQ: HEES) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. (12/11/2019)
#15 - Etsy (NASDAQ:ETSY)

Number of Downgrades: 12 (in the last 90 days)
Consensus Rating: Buy
Rating Score: 2.7
Ratings Breakdown: 13 Buy Ratings, 3 Hold Ratings, 1 Sell Ratings.
Consensus Price Target: $66.52 (31.7% Upside)

Etsy logoEtsy, Inc. operates Etsy.com, a commerce platform to make, sell, and buy goods online and offline primarily in the United States, United Kingdom, Canada, Australia, France, and Germany. It provides various seller services and tools that are designed to help entrepreneurs for starting, managing, and scaling their businesses. The company offers approximately 50 million items across approximately 50 retail categories to buyers. It also provides various seller services, including Etsy payments, a payment processing service; promoted listings, an on-site advertising service that allows sellers to pay for prominent placement of their listings in search results; shipping labels, which allows sellers in the United States and Canada to purchase discounted shipping labels; and pattern, a service that allows sellers to build custom Websites, as well as offers seller tools and education resources to manage the administrative side of their businesses. Etsy, Inc. was founded in 2005 and is headquartered in Brooklyn, New York.

Recent Recommendations for Etsy:

  • Etsy Inc (NASDAQ: ETSY) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. (1/17/2020)
  • Etsy Inc (NASDAQ: ETSY) had its "buy" rating re-affirmed by analysts at Nomura. They now have a $61.00 price target on the stock. (1/6/2020)
  • Etsy Inc (NASDAQ: ETSY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. (12/31/2019)
  • Etsy Inc (NASDAQ: ETSY) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. (12/17/2019)
  • Etsy Inc (NASDAQ: ETSY) is now covered by analysts at SunTrust Banks, Inc.. They set a "buy" rating and a $55.00 price target on the stock. (12/13/2019)
  • Etsy Inc (NASDAQ: ETSY) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $64.00 price target on the stock. (12/12/2019)
  • Etsy Inc (NASDAQ: ETSY) was downgraded by analysts at Morgan Stanley from an "equal weight" rating to an "underweight" rating. They now have a $38.00 price target on the stock. (12/5/2019)
  • Etsy Inc (NASDAQ: ETSY) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. (12/4/2019)
  • Etsy Inc (NASDAQ: ETSY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. (11/27/2019)
  • Etsy Inc (NASDAQ: ETSY) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. (11/20/2019)
#16 - IAC/InterActiveCorp (NASDAQ:IAC)

Number of Downgrades: 12 (in the last 90 days)
Consensus Rating: Buy
Rating Score: 2.8
Ratings Breakdown: 17 Buy Ratings, 4 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $286.50 (8.8% Upside)

IAC/InterActiveCorp logoIAC/InterActiveCorp, together with its subsidiaries, operates as a media and Internet company in the United States and internationally. The company's Match Group segment provides subscription dating products under the Tinder, Match, PlentyOfFish, Meetic, OkCupid, OurTime, Pairs and Hinge, and other brands. Its ANGI Homeservices segment connects homeowners to home service professionals, collects reviews, and allows homeowners to research, match, and connect on-demand to network of service professionals online, through mobile apps, or by voice assistants under the HomeAdvisor, Angie's List, and Handy brand names. The company's Vimeo segment operates a video platform for professionals, marketers, and enterprises to connect with audiences, customers, and employees; provides cloud-based software products to stream, host, distribute, and monetize videos online and across devices, as well as video tools on a subscription basis; and sells live streaming accessories. Its Dotdash segment offers a portfolio of digital brands providing information and inspiration in various vertical content categories. The company's Applications segment owns and operates a portfolio of desktop browser applications that provide users with access to various online content, tools, and services; develops, distributes, and offers a suite of Slimware desktop-support software and services. This segment also offers subscription-based mobile applications. Its Emerging & Other segment operates a collection of Websites, which offers general search services and information; on-demand staffing platform that connect workers for warehouse, delivery and moving, data entry, and customer service; operates news, commentary, culture, and entertainment Website; and offers digital content, as well as production and producer services for feature films. IAC/InterActiveCorp was founded in 1986 and is headquartered in New York, New York.

Recent Recommendations for IAC/InterActiveCorp:

  • IAC/InterActiveCorp (NASDAQ: IAC) had its "buy" rating re-affirmed by analysts at Wells Fargo & Co. (1/19/2020)
  • IAC/InterActiveCorp (NASDAQ: IAC) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. (1/18/2020)
  • IAC/InterActiveCorp (NASDAQ: IAC) had its price target raised by analysts at UBS Group AG from $290.00 to $310.00. They now have a "buy" rating on the stock. (1/17/2020)
  • IAC/InterActiveCorp (NASDAQ: IAC) had its price target raised by analysts at Wells Fargo & Co from $285.00 to $320.00. (1/17/2020)
  • IAC/InterActiveCorp (NASDAQ: IAC) was upgraded by analysts at Zacks Investment Research from a "strong sell" rating to a "hold" rating. (1/11/2020)
  • IAC/InterActiveCorp (NASDAQ: IAC) had its price target raised by analysts at Oppenheimer Holdings Inc. from to . They now have an "outperform" rating on the stock. (1/9/2020)
  • IAC/InterActiveCorp (NASDAQ: IAC) had its "buy" rating re-affirmed by analysts at Guggenheim. (1/8/2020)
  • IAC/InterActiveCorp (NASDAQ: IAC) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong sell" rating. (1/4/2020)
  • IAC/InterActiveCorp (NASDAQ: IAC) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. (12/25/2019)
  • IAC/InterActiveCorp (NASDAQ: IAC) is now covered by analysts at Wedbush. They set an "outperform" rating and a $295.00 price target on the stock. (12/23/2019)
#17 - Petrofac (LON:PFC)

Number of Downgrades: 12 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 2.3
Ratings Breakdown: 5 Buy Ratings, 10 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: GBX 510.08 (42.6% Upside)

Petrofac logoPetrofac Limited, an oilfield service company, provides facilities solutions to the oil and gas production and processing industry worldwide. It operates through three segments: Engineering & Construction, Engineering & Production Services, and Integrated Energy Services. The Engineering & Construction segment provides engineering, procurement, and construction project execution services to the onshore oil and gas industry. The Engineering & Production Services segment offers concept, feasibility, and front-end engineering and design studies, as well as a range of operations, maintenance, and engineering services for onshore and offshore projects. The Integrated Energy Services segment provides an integrated service for clients under flexible commercial models that are aligned with their requirements in projects, including upstream developments, related energy infrastructure projects, and investments. Petrofac Limited was founded in 1981 and is headquartered in London, the United Kingdom.

Recent Recommendations for Petrofac:

  • Petrofac Limited (LON: PFC) had its price target lowered by analysts at Goldman Sachs Group Inc from GBX 508 to GBX 483. They now have a "neutral" rating on the stock. (1/21/2020)
  • Petrofac Limited (LON: PFC) had its price target lowered by analysts at JPMorgan Chase & Co. from GBX 450 to GBX 410. They now have a "neutral" rating on the stock. (12/19/2019)
  • Petrofac Limited (LON: PFC) was downgraded by analysts at Kepler Capital Markets to a "hold" rating. They now have a GBX 420 price target on the stock, down previously from GBX 610. (12/19/2019)
  • Petrofac Limited (LON: PFC) had its price target lowered by analysts at Barclays PLC from GBX 600 to GBX 570. They now have an "overweight" rating on the stock. (12/18/2019)
  • Petrofac Limited (LON: PFC) had its price target lowered by analysts at Oddo Securities from GBX 400 to GBX 383. They now have a "neutral" rating on the stock. (12/18/2019)
  • Petrofac Limited (LON: PFC) had its price target lowered by analysts at Berenberg Bank from GBX 500 to GBX 420. They now have a "hold" rating on the stock. (12/18/2019)
  • Petrofac Limited (LON: PFC) had its price target lowered by analysts at Societe Generale from GBX 740 to GBX 595. They now have a "buy" rating on the stock. (12/18/2019)
  • Petrofac Limited (LON: PFC) had its price target lowered by analysts at Goldman Sachs Group Inc from GBX 540 to GBX 508. They now have a "neutral" rating on the stock. (12/17/2019)
  • Petrofac Limited (LON: PFC) had its "neutral" rating re-affirmed by analysts at UBS Group AG. (12/16/2019)
  • Petrofac Limited (LON: PFC) had its price target lowered by analysts at JPMorgan Chase & Co. from GBX 460 to GBX 450. They now have a "neutral" rating on the stock. (12/11/2019)
#18 - Hunting (LON:HTG)

Number of Downgrades: 12 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 2.5
Ratings Breakdown: 6 Buy Ratings, 4 Hold Ratings, 1 Sell Ratings.
Consensus Price Target: GBX 541.18 (63.2% Upside)

Hunting logoHunting PLC, together with its subsidiaries, manufactures and distributes tools and equipment for the upstream energy industry worldwide. The company offers perforating guns and accessories; and connections, oil country tubular goods, drilling tools, subsea equipment, intervention tools, and electronics. It also provides deep hole drilling and precision machining services; and well intervention services. In addition, the company engages in the oil and gas exploration and production activities. Hunting PLC was founded in 1874 and is headquartered in London, the United Kingdom.

Recent Recommendations for Hunting:

  • Hunting plc (LON: HTG) had its price target lowered by analysts at Goldman Sachs Group Inc from GBX 420 to GBX 402. They now have a "sell" rating on the stock. (1/21/2020)
  • Hunting plc (LON: HTG) had its "buy" rating re-affirmed by analysts at UBS Group AG. They now have a GBX 510 price target on the stock, down previously from GBX 590. (1/8/2020)
  • Hunting plc (LON: HTG) had its price target lowered by analysts at JPMorgan Chase & Co. from GBX 490 to GBX 460. They now have a "neutral" rating on the stock. (12/18/2019)
  • Hunting plc (LON: HTG) had its price target lowered by analysts at Berenberg Bank from GBX 480 to GBX 450. They now have a "hold" rating on the stock. (12/18/2019)
  • Hunting plc (LON: HTG) had its "buy" rating re-affirmed by analysts at UBS Group AG. (12/16/2019)
  • Hunting plc (LON: HTG) had its price target lowered by analysts at Barclays PLC from GBX 530 to GBX 500. They now have an "equal weight" rating on the stock. (12/13/2019)
  • Hunting plc (LON: HTG) had its price target lowered by analysts at JPMorgan Chase & Co. from GBX 642 to GBX 490. They now have a "neutral" rating on the stock. (12/11/2019)
  • Hunting plc (LON: HTG) was downgraded by analysts at Credit Suisse Group AG to a "neutral" rating. They now have a GBX 430 price target on the stock, down previously from GBX 530. (12/10/2019)
  • Hunting plc (LON: HTG) had its price target lowered by analysts at Jefferies Financial Group Inc from GBX 520 to GBX 470. They now have a "buy" rating on the stock. (12/9/2019)
  • Hunting plc (LON: HTG) had its price target lowered by analysts at Canaccord Genuity from GBX 650 to GBX 475. They now have a "buy" rating on the stock. (11/14/2019)
#19 - Premier (NASDAQ:PINC)

Number of Downgrades: 12 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 2.3
Ratings Breakdown: 4 Buy Ratings, 8 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $40.67 (13.8% Upside)

Premier logoPremier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. The company operates through two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and document shredding services and software-as-a-service informatics products. This segment also engages in the Integrated Pharmacy business, which provides traditional pharmacy dispensing and integrated pharmacy services; direct sourcing business; and provision of ASCEND Collaborative service for members to receive group purchasing programs, tiers, and prices, as well as managed services. The Performance Services segment offers PremierConnect for members to address existing cost and quality imperatives, help them manage a value-based care reimbursement model and support their regulatory reporting framework; performance improvement collaborative; and consulting and insurance services. This segment's various PremierConnect domains comprise PremierConnect Quality & Regulatory domain for identifying and targeting quality improvement areas; PremierConnect Clinical Surveillance & Safety domain to enhance patient safety; PremierConnect Supply Chain & ERP domain to deals with supply chain; PremierConnect Operations domain, which optimizes labor management with integrated financial reporting and budgeting; and PremierConnect Enterprise Analytics, which integrates members' custom data into a hosted and integrated data warehouse and analytics platform. The company was incorporated in 2013 and is headquartered in Charlotte, North Carolina.

Recent Recommendations for Premier:

  • Premier Inc (NASDAQ: PINC) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. (1/23/2020)
  • Premier Inc (NASDAQ: PINC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. (1/23/2020)
  • Premier Inc (NASDAQ: PINC) had its "buy" rating re-affirmed by analysts at Barclays PLC. They now have a $44.00 price target on the stock. (1/19/2020)
  • Premier Inc (NASDAQ: PINC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $40.00 price target on the stock. (1/14/2020)
  • Premier Inc (NASDAQ: PINC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. (1/4/2020)
  • Premier Inc (NASDAQ: PINC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $42.00 price target on the stock. (1/2/2020)
  • Premier Inc (NASDAQ: PINC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. (12/28/2019)
  • Premier Inc (NASDAQ: PINC) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. (12/27/2019)
  • Premier Inc (NASDAQ: PINC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $43.00 price target on the stock. (12/26/2019)
  • Premier Inc (NASDAQ: PINC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. (12/12/2019)
#20 - Wright Medical Group (NASDAQ:WMGI)

Number of Downgrades: 12 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 2.2
Ratings Breakdown: 3 Buy Ratings, 11 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $29.05 (-4.2% Upside)

Wright Medical Group logoWright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth. It also provides sports medicines and other products to mechanically repair tissue-to-tissue or tissue-to-bone injuries, as well as other ancillary products. The company primarily offers its products to orthopedic, trauma, and podiatric surgeons. It markets and sells its products through direct sales representatives, independent sales agencies, direct sales offices, and distributors. The company was founded in 1999 and is headquartered in Amsterdam, the Netherlands.

Recent Recommendations for Wright Medical Group:

  • Wright Medical Group NV (NASDAQ: WMGI) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. (1/25/2020)
  • Wright Medical Group NV (NASDAQ: WMGI) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. (1/11/2020)
  • Wright Medical Group NV (NASDAQ: WMGI) was downgraded by analysts at Jefferies Financial Group Inc from a "buy" rating to a "hold" rating. They now have a $30.75 price target on the stock. (12/23/2019)
  • Wright Medical Group NV (NASDAQ: WMGI) had its "hold" rating re-affirmed by analysts at Wells Fargo & Co. (12/6/2019)
  • Wright Medical Group NV (NASDAQ: WMGI) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. (11/29/2019)
  • Wright Medical Group NV (NASDAQ: WMGI) was downgraded by analysts at Leerink Swann from an "outperform" rating to a "market perform" rating. (11/27/2019)
  • Wright Medical Group NV (NASDAQ: WMGI) was downgraded by analysts at Svb Leerink Llc from an "outperform" rating to a "market perform" rating. (11/18/2019)
  • Wright Medical Group NV (NASDAQ: WMGI) was downgraded by analysts at Leerink Swann from an "outperform" rating to a "market perform" rating. (11/18/2019)
  • Wright Medical Group NV (NASDAQ: WMGI) was upgraded by analysts at TheStreet from a "d+" rating to a "c-" rating. (11/18/2019)
  • Wright Medical Group NV (NASDAQ: WMGI) had its price target lowered by analysts at Needham & Company LLC from $32.00 to $30.75. They now have a "buy" rating on the stock. (11/15/2019)




Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel